PR, functioning as a regulatory gene for estrogen and ER (Li et al., 2022a), stands as a pivotal prognostic biomarker, influencing both the overall survival rate and disease-free survival rate in breast cancer patients (Mohammed et al., 2015). This evidence concerns the gene PGR and breast carcinoma.